Nebraska
The next meeting of the Drug Utilization Review (DUR) Board will be May 11, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The next meeting of the Drug Utilization Review (DUR) Board will be May 11, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy issued a proposed rule establishing standards for pharmacist prescribing of protocol formulary dangerous drugs and prescribing of dangerous drugs in conjunction with point-of-care testing. The rule also revises the definition of “hormonal contraception drug therapy” to include formulary products delineated in the written contraception protocol, including emergency contraception, and clarifies reporting of vaccine administration. The Board will hold a virtual hearing during their April 22-23 meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The North Carolina Department of Health and Human Services (NCDHHS) has no-cost antigen tests they would like to share with retail businesses that are interested in screening their employees for COVID-19. The Department of Health and Human Services will also arrange an orientation call with any NCRMA member to discuss what you need to do to request and receive the free tests from DHHS. The North Carolina Department of Health and Human Services has a supply of Abbott BinaxNOW rapid, point-of-care antigen testing supplies available to support testing efforts to quickly identify and respond to cases of COVID-19. Facilities interested in receiving tests from the state must meet ALL the following requirements:
Request process: All facilities that meet the above requirements may apply to request tests via the request form.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Gov. Doug Burgum (R) signed several bills of interest to chain pharmacy as emergency measures:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published a notice to announce the reiteration of certain emergency orders issued in response to the COVID-19 public health emergency, including the suspension of the prohibition on performing remote order entry from an unpermitted site, the temporary authorization of automated pharmacy pickup kiosks, and the establishment of safe harbor provisions concerning personal protective equipment. The notice also reiterates the authorization of a one-time early refill of Schedule III, IV, and V prescriptions for valid refills, and the dispensing of Schedule II controlled substances under specified conditions.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The House Public Health Committee held hearings on two bills supported by NACDS members: HB 678 by Rep. Phil Cortez (D) that amends existing laws making permanent pharmacists’ authority to initiate, order, and administer childhood vaccines to anyone 3 and older without a prescription, and HB 2049 by Rep. Donna Howard (D) that would allow pharmacists to test and treat for flu and strep. NACDS members are encouraged to call the House Public Health Committee members to urge them to vote both bills out of the Committee so they can be set for a vote by the House of Representatives.
Photo Caption – (L-R) NACDS chain pharmacists Casey Nichols with Walgreens, Jeff Loesch with Kroger Health, and Aimee Lusson with Walgreens meet with immunization bill sponsor Rep. Phil Cortez in the Texas State Capitol after the House Public Health Committee hearing.
Also in Texas, the Health and Human Services Commission is hosting two vaccine webinars:
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy has asked that we remind members that the emergency rule requiring pharmacy technician trainees to be enrolled in a training program upon registration with the Board became effective January 3.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Gov. Jim Justice (R) recently signed the following bills:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy’s emergency rule amends regulations under Chapter 16 to clarify standards for pharmacists to provide immunizations during the COVID-19 public health emergency. The rule removes the definition of “private space” and the requirement that the individual receiving a vaccine be seated in a chair with back support. The rule also adds vaccines approved by the FDA under the Emergency Use Authorization for COVID-19. The rule extends December 9, emergency rule and became effective April 7, and expires August 5, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.